New Plague Sustained Release Tablet 300mg (Sarpogrelate Hydrochloride)

Adult dose

Administer 300mg of Sarpogrelate Hydrochloride sustained release tablet orally once daily after meals. This medication should be taken whole and not chewed or crushed.

This drug should not be used in patients with bleeding as it may increase the risk of bleeding. It is safest for women who are pregnant or may become pregnant to avoid taking this medication. Patients who are menstruating or have a tendency to bleed should use this drug with caution, as those taking anticoagulants or platelet aggregation inhibitors may have an increased risk of bleeding. Patients with severely impaired renal function or the elderly need special attention when using this drug. It is important to undergo regular blood tests to monitor for adverse reactions or signs of bleeding during treatment. Rarely, side effects such as rash, indigestion, headache, cough, and blood pressure changes may occur, and if symptoms are severe, immediate consultation with healthcare professionals is necessary. When taken with anticoagulants or platelet aggregation inhibitors, the risk of bleeding may increase, so consultation with a physician is essential before concurrent use. Pregnant or breastfeeding women are advised to avoid taking this medication, and if unavoidable, it is recommended to consult with a specialist and discontinue breastfeeding. The safety of this drug in children has not been established, thus it is advisable not to use it in pediatric patients. This medication should be stored out of reach of children, and transferring it to another container may alter its quality, so caution should be taken.

Serious side effects

Rash, chest tightness, difficulty breathing, jaundice (yellowing of the skin), severe general malaise, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output, severe swelling of the body with associated high blood pressure, gastrointestinal bleeding (hematemesis and melena), cerebral hemorrhage, subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia, liver dysfunction and jaundice

Mild side effects

• Pharyngitis
• conjunctivitis
• upper respiratory tract infection
• indigestion
• constipation
• diarrhea
• gastritis
• gastrointestinal dysfunction
• hypoglycemia
• decreased appetite

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be preserved for a longer period.

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle